Laboratorio Farmaceutico Erfo Future Growth
Future criteria checks 2/6
Laboratorio Farmaceutico Erfo is forecast to grow earnings and revenue by 17.6% and 14.3% per annum respectively. EPS is expected to grow by 16.2% per annum. Return on equity is forecast to be 10.2% in 3 years.
Key information
17.6%
Earnings growth rate
16.2%
EPS growth rate
| Personal Products earnings growth | 8.0% |
| Revenue growth rate | 14.3% |
| Future return on equity | 10.2% |
| Analyst coverage | Low |
| Last updated | 10 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 9 | 1 | 1 | 2 | 1 |
| 12/31/2025 | 7 | 1 | 1 | 2 | 1 |
| 12/31/2024 | 7 | 1 | 1 | 1 | 1 |
| 6/30/2024 | 6 | 0 | 1 | 1 | N/A |
| 3/31/2024 | 6 | 1 | 0 | 1 | N/A |
| 12/31/2023 | 6 | 1 | 0 | 1 | N/A |
| 9/30/2023 | 6 | 1 | -1 | 1 | N/A |
| 6/30/2023 | 5 | 1 | -1 | 1 | N/A |
| 3/31/2023 | 5 | 1 | -1 | 1 | N/A |
| 12/31/2022 | 5 | 1 | 0 | 1 | N/A |
| 9/30/2022 | 5 | 1 | N/A | N/A | N/A |
| 6/30/2022 | 5 | 1 | N/A | N/A | N/A |
| 3/31/2022 | 5 | 1 | N/A | N/A | N/A |
| 12/31/2021 | 5 | 1 | 2 | 2 | N/A |
| 12/31/2020 | 4 | 1 | 1 | 1 | N/A |
| 12/31/2019 | 5 | 1 | N/A | N/A | N/A |
| 12/31/2018 | 4 | 1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RK7's forecast earnings growth (17.6% per year) is above the savings rate (1%).
Earnings vs Market: RK7's earnings (17.6% per year) are forecast to grow slower than the German market (20.9% per year).
High Growth Earnings: RK7's earnings are forecast to grow, but not significantly.
Revenue vs Market: RK7's revenue (14.3% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: RK7's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RK7's Return on Equity is forecast to be low in 3 years time (10.2%).